Myriad Genetics
MYGN
MYGN
187 hedge funds and large institutions have $1.49B invested in Myriad Genetics in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 59 increasing their positions, 66 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 66
15% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 27
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
187
Holding in Top 10
–
Calls
$4.39M
Puts
$2.95M
Top Buyers
| 1 | +$35.3M | |
| 2 | +$28.3M | |
| 3 | +$18.3M | |
| 4 |
Goldman Sachs
New York
|
+$10.3M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$9.73M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$13.4M | |
| 3 | -$12.3M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$10.2M |
| 5 |
Two Sigma Investments
New York
|
-$7.28M |